We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

52 hedge funds and large institutions have $83.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 9

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

8% more funds holding

Funds holding: 48 → 52 (+4)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

67% less capital invested

Capital invested by funds: $253M → $83.8M (-$170M)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
21
Reduced
9
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.57M
2
EWM
Evercore Wealth Management
New York
+$835K
3
BlackRock
BlackRock
New York
+$696K
4
Millennium Management
Millennium Management
New York
+$588K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$501K

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$4.46M
2
ABG
Ally Bridge Group
New York
-$3.63M
3
CCM
CAAS Capital Management
New York
-$2.12M
4
SI
Sofinnova Investments
California
-$2.04M
5
SFM
Sphera Funds Management
Israel
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$18.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$17M +$2.57M +452,240 +11%
RCM
3
RA Capital Management
Massachusetts
$12.6M – – –
OMC
4
OUP Management Company
Pennsylvania
$9.33M – – –
APM
5
Avidity Partners Management
Texas
$6.97M +$2.63K +462 +0%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$6.49M -$870K -152,811 -8%
BBA
7
Baker Bros. Advisors
New York
$3.06M – – –
BlackRock
8
BlackRock
New York
$2.51M +$696K +122,324 +23%
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.45M +$237K +41,720 +12%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$852K +$501K +88,089 +64%
Morgan Stanley
11
Morgan Stanley
New York
$600K +$411K +72,159 +83%
Millennium Management
12
Millennium Management
New York
$585K +$588K +103,227 +199%
EWM
13
Evercore Wealth Management
New York
$553K +$835K +146,676 New
Northern Trust
14
Northern Trust
Illinois
$521K +$375K +65,819 +91%
State Street
15
State Street
Massachusetts
$515K +$124K +21,702 +19%
CCM
16
CAAS Capital Management
New York
$396K -$2.12M -372,419 -78%
Renaissance Technologies
17
Renaissance Technologies
New York
$369K +$408K +71,600 +273%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$271K +$274K +48,146 +203%
Citadel Advisors
19
Citadel Advisors
Florida
$162K +$243K +42,746 New
Charles Schwab
20
Charles Schwab
California
$158K +$109K +19,111 +84%
UBS Group
21
UBS Group
Switzerland
$120K -$16.7K -2,930 -8%
PPA
22
Parametric Portfolio Associates
Washington
$105K +$159K +27,924 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$94K +$44.7K +7,855 +46%
Bank of America
24
Bank of America
North Carolina
$92K +$50.6K +8,886 +58%
JF
25
Jump Financial
Illinois
$80K +$121K +21,300 New
1
2 3

CYT Hedge Fund Activity: Q1 2022 in Review

52 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q1 2022, worth a combined $83.8M — down 67% from $253M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CYT positions and 9 closed out — a net gain of 4 holders — while 21 added to existing stakes and 9 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $2.57M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $4.46M sold.

  • 52 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q1 2022, up from 48 in Q4 2021.
  • Funds reported $83.8M of Cyteir Therapeutics, Inc. Common Stock stock for Q1 2022, down 67% quarter-over-quarter.
  • 13 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q1 2022 and 9 closed out, a net change of +4 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q1 2022 was Fidelity Investments, an estimated $2.57M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q1 2022 was Acuta Capital Partners, an estimated $4.46M sold.

Based on aggregated 13F filings for Q1 2022.